Moussa81 Buying quality companies at reasonable prices remains a winning investment strategy in my opinion despite all the noise around high-flying Al names on the market today. What's even better is if those stocks pay you a decent yield for holding onto them, which makes natural price volatility easier to bear. This brings me to Medtronic (NYSE:MDT), which I last covered in August with a 'Buy' rating, noting its undervaluation, strong balance sheet, and positioning for international growth. Since my l ...